Wall Street Zen Downgrades McKesson to Hold

Analysts cite concerns about the company's performance and outlook.

Mar. 14, 2026 at 5:50am

Got story updates? Submit your updates here. ›

Wall Street Zen, an investment research firm, has downgraded shares of McKesson Corporation (NYSE: MCK) from a "buy" rating to a "hold" rating in a new report. The move comes as analysts at the firm express concerns about the company's recent performance and future outlook.

Why it matters

McKesson is one of the largest pharmaceutical distributors in the United States, serving as a critical link between drug manufacturers and healthcare providers. The downgrade from Wall Street Zen could signal broader concerns about the company's ability to navigate challenges in the healthcare industry and maintain its strong market position.

The details

In the report, Wall Street Zen analysts cited a number of factors that led to the downgrade, including weaker-than-expected financial results and a less favorable outlook for the company's future growth. The firm also noted increased competition and pricing pressures in the pharmaceutical distribution market, which could put pressure on McKesson's profit margins.

  • Wall Street Zen issued the downgrade report on Saturday, March 14, 2026.

The players

Wall Street Zen

An investment research firm that provides analysis and recommendations on publicly traded companies.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The downgrade from Wall Street Zen highlights the challenges facing McKesson and the broader pharmaceutical distribution industry, as companies navigate increased competition, pricing pressures, and changing market dynamics. Investors will be closely watching to see how McKesson responds to these challenges and whether the company can maintain its market-leading position.